Remon, J <br/><br/>
Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?  [electronic resource] 

 -  Cancer treatment reviews  Dec 2018 
 - 47-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1532-1967 
<br/><br/><label>Standard No.: </label>10.1016/j.ctrv.2018.10.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase--genetics<br/>B7-H1 Antigen--metabolism<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>ErbB Receptors--genetics<br/>Humans<br/>Immunotherapy--methods<br/>Lung Neoplasms--genetics<br/>Mutation<br/>Oncogene Proteins--genetics<br/>Protein-Tyrosine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-met--genetics<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Receptor, ErbB-2--genetics